Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Total Non-Current Liabilities

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Liabilities ₹144 Cr₹111 Cr₹108 Cr₹125 Cr₹159 Cr

What is the latest Total Non-Current Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Total Non-Current Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹144 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹144 Cr
Mar2025₹111 Cr
Mar2024₹108 Cr
Mar2023₹125 Cr
Mar2022₹159 Cr

How is Total Non-Current Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹144 Cr
29.59
Mar2025 ₹111 Cr
2.80
Mar2024 ₹108 Cr
-14.10
Mar2023 ₹125 Cr
-21.01
Mar2022 ₹159 Cr -

Compare Total Non-Current Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹46,185.2 Cr 9% 7.7% 4.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹454,914.0 Cr 3.9% 7.8% 13% Stock Analytics
DIVIS LABORATORIES ₹300,380.0 Cr 11.5% 20.6% 68% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,169.0 Cr 1% 1.8% 34.3% Stock Analytics
DR REDDYS LABORATORIES ₹114,933.0 Cr 1.1% 11.8% 14.9% Stock Analytics
CIPLA ₹114,478.0 Cr 1.1% 7.9% -6.3% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

9%

7.7%

4.2%

SENSEX

5.9%

13%

-1.9%


You may also like the below Video Courses